Annual Shareholders Equity
$308.40 M
-$155.77 M-33.56%
31 December 2023
Summary:
Adaptive Biotechnologies annual stockholders equity is currently $308.40 million, with the most recent change of -$155.77 million (-33.56%) on 31 December 2023. During the last 3 years, it has fallen by -$434.87 million (-58.51%). ADPT annual shareholders equity is now -58.51% below its all-time high of $743.27 million, reached on 31 December 2020.ADPT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$223.77 M
-$17.83 M-7.38%
30 September 2024
Summary:
Adaptive Biotechnologies quarterly stockholders equity is currently $223.77 million, with the most recent change of -$17.83 million (-7.38%) on 30 September 2024. Over the past year, it has dropped by -$137.96 million (-38.14%). ADPT quarterly shareholders equity is now -71.13% below its all-time high of $775.05 million, reached on 30 September 2020.ADPT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADPT Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -33.6% | -38.1% |
3 y3 years | -58.5% | -65.7% |
5 y5 years | +219.5% | -61.8% |
ADPT Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -58.5% | at low | -65.7% | at low |
5 y | 5 years | -58.5% | +219.5% | -71.1% | at low |
alltime | all time | -58.5% | +219.5% | -71.1% | +178.7% |
Adaptive Biotechnologies Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $223.77 M(-7.4%) |
June 2024 | - | $241.60 M(-12.1%) |
Mar 2024 | - | $274.91 M(-10.9%) |
Dec 2023 | $308.40 M(-33.6%) | $308.40 M(-14.7%) |
Sept 2023 | - | $361.73 M(-8.7%) |
June 2023 | - | $396.04 M(-6.6%) |
Mar 2023 | - | $424.02 M(-8.6%) |
Dec 2022 | $464.17 M(-23.2%) | $464.17 M(-4.9%) |
Sept 2022 | - | $487.84 M(-5.9%) |
June 2022 | - | $518.30 M(-6.3%) |
Mar 2022 | - | $553.21 M(-8.4%) |
Dec 2021 | $603.99 M | $603.99 M(-7.3%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $651.51 M(-6.0%) |
June 2021 | - | $693.18 M(-4.5%) |
Mar 2021 | - | $725.59 M(-2.4%) |
Dec 2020 | $743.27 M(+30.2%) | $743.27 M(-4.1%) |
Sept 2020 | - | $775.05 M(+46.3%) |
June 2020 | - | $529.94 M(-3.9%) |
Mar 2020 | - | $551.56 M(-3.4%) |
Dec 2019 | $571.04 M(-321.2%) | $571.04 M(-2.5%) |
Sept 2019 | - | $585.92 M(-306.0%) |
June 2019 | - | -$284.37 M(-198.7%) |
Mar 2019 | - | $288.10 M(-211.6%) |
Dec 2018 | -$258.11 M(+14.9%) | -$258.11 M |
Dec 2017 | -$224.62 M | - |
FAQ
- What is Adaptive Biotechnologies annual stockholders equity?
- What is the all time high annual shareholders equity for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual shareholders equity year-on-year change?
- What is Adaptive Biotechnologies quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly shareholders equity year-on-year change?
What is Adaptive Biotechnologies annual stockholders equity?
The current annual shareholders equity of ADPT is $308.40 M
What is the all time high annual shareholders equity for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual stockholders equity is $743.27 M
What is Adaptive Biotechnologies annual shareholders equity year-on-year change?
Over the past year, ADPT annual stockholders equity has changed by -$155.77 M (-33.56%)
What is Adaptive Biotechnologies quarterly stockholders equity?
The current quarterly shareholders equity of ADPT is $223.77 M
What is the all time high quarterly shareholders equity for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly stockholders equity is $775.05 M
What is Adaptive Biotechnologies quarterly shareholders equity year-on-year change?
Over the past year, ADPT quarterly stockholders equity has changed by -$137.96 M (-38.14%)